About us
Espace utilisateur
INSTN offers more than 40 diplomas from operator level to post-graduate degree level. 30% of our students are international students.
Professionnal development
Professionnal development
Find a training course
INSTN delivers off-the-self or tailor-made training courses to support the operational excellence of your talents.
Human capital solutions
At INSTN, we are committed to providing our partners with the best human capital solutions to develop and deliver safe & sustainable projects.
Home   /   Thesis   /   Development of innovative medical devices from new bacterial polyhydroxyalkanoates (PHA) derivatives.

Development of innovative medical devices from new bacterial polyhydroxyalkanoates (PHA) derivatives.

Chemistry Condensed matter physics, chemistry & nanosciences Health and environment technologies, medical devices Technological challenges


To address the future challenges of wearable or implanted medical devices (MDs), which are less invasive and increasingly personalized and effective, it is necessary to have a broad range of biocompatible materials with diverse mechanical properties. Preferably, these biomaterials should be of biological origin and employed under mild conditions (preferably in water) to reduce the risk of releasing toxic by-products. Material biodegradability is another key characteristic to master for the development of prostheses and devices with a lifespan adapted to their use. In this context, the ANR PHAMOUS aims to demonstrate the high potential of bacterial polyhydroxyalkanoates (PHA) for designing innovative MDs.
In this framework, the doctoral candidate will initially be responsible for the chemical modification of various PHAs to enhance their water solubility (e.g., pendant PEG groups), introduce photo-crosslinkable groups (e.g., methacrylates), and incorporate specific functions (peptides) to enhance cellular adhesion and antimicrobial properties. The doctoral candidate will then use the different functionalized PHAs to develop two demonstrators implemented through two different processes. Photo-crosslinkable and solvent-soluble PHAs will be formulated to manufacture a prototype of a bronchial stent using "vat polymerization" 3D printing processes. Simultaneously, electrospinning of PHAs will be used to develop micro-structured and porous membranes.


Département des Technologies des NanoMatériaux (LITEN)
Service Architecture 3D
Laboratoire de Formulation des Matériaux
Université Grenoble Alpes
Top envelopegraduation-hatlicensebookuserusersmap-markercalendar-fullbubblecrossmenuarrow-down